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Article abstract-We attempted to characterize the changes in cognition associated with the earliest, or preclinical, 
stages of Alzheimer’s disease (AD) by administering a comprehensive neuropsychological test battery to a group of ini- 
tially nondemented older adults participating in a prospective epidemiologic study of dementia. Using Cox regression 
analyses, we examined the associations between baseline neuropsychological test scores and subsequent development 
of AD. Results confirmed preliminary findings that baseline scores on the Boston Naming Test, Immediate Recall on 
the Selective Reminding Test, and the Similarities subtest of the Wechsler Adult Intelligence Scale-Revised were sig- 
nificantly and independently associated with later diagnosis of AD. Analyses controlled for the effects of age, educa- 
tion, sex, and language of test administration. These results lend support to the notion of a preclinical phase of AD and 
indicate that this very early stage of AD is characterized by poor word-finding ability, abstract reasoning, and memory. 
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Early detection of Alzheimer’s disease (AD) is im- 
portant both for clinical care of patients and for im- 
proving our understanding of this disorder. Be- 
cause neuropsychological tests can detect very sub- 
tle cognitive impairment, they may be sensitive to  
early changes in cognition that might occur well be- 
fore frank dementia becomes apparent. Therefore, 
neuropsychological tests may be useful for identify- 
ing individuals in the very earliest, or preclinical, 
stages of AD. 
Previous studies examining the neuropsychologi- 
cal characteristics of preclinical dementia generally 
have focused on the assessment of memory. Fuld et 
al,’ Masur et a1,2 and Tuokko et a13 prospectively 
followed cohorts of initially nondemented elderly 
people and compared baseline memory testing of 
subjects who later became demented with the base- 
line testing of subjects whose cognitive functioning 
remained unchanged. Results from these studies 
indicate that performance on the Fuld Object Mem- 
ory Evaluation,’ the Buschke Selective Reminding 
Test (SRT),2 and a cued recall task3 differentiates 
subjects who later become demented from those 
who remain nondemented. 
Since memory impairment is a defining feature 
of dementia, tests of memory should be useful for 
identifying patients who are in the incipient stages 
of a dementing disorder. Masur et a14 recently re- 
ported that in addition to two memory measures, 
baseline scores on the Digit Symbol subtest of the 
Wechsler Adult Intelligence Scale-Revised (WAIS- 
R)j and a verbal fluency measure independently 
contributed to the prediction of later dementia in 
their cohort of initially healthy elderly people from 
the Bronx Aging Study. Similarly, preliminary re- 
sults from our cohort of initially nondemented el- 
derly subjects in the North Manhattan Aging Proj- 
ect indicate that tests of verbal abstract reasoning 
and word-finding are significant predictors of later 
dementia, independent of performance on memory 
testing.6 Our finding was based upon a matched 
case-control comparison of 26 initially nonde- 
mented subjects who developed dementia by l-year 
follow-up and 26 subjects who remained nonde- 
mented. We evaluated the predictive value of each 
test in a comprehensive neuropsychological test 
battery to  identify at  baseline those subjects who 
would subsequently be diagnosed as having demen- 
tia. The measures with the highest positive predic- 
tive value (PV+) (ie, percentage of subjects identi- 
fied as at risk who actually became demented) were 
a 15-item version of the Boston Naming Test (PV+ 
= go%), Immediate Recall on the Selective Remind- 
ing Test (PV+ = 88%), and WAIS-R Similarities 
(PV+ = 79%). In contrast to previous reports, De- 
layed Recall on the Selective Reminding Test was 
not a good predictor of later dementia (PV+ = 50%). 
We conducted the current study to confirm these 
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preliminary findings in a larger sample of prospec- 
tively followed older adults from our community- 
based cohort. 
Methods. Subjects. Data were obtained from subjects 
participating in the North Manhattan Aging Project, a 
community-based, epidemiologic study of dementia in 
northern Manhattan, NY. All subjects included in the 
analyses presented here had completed at least one an- 
nual follow-up evaluation. Because we were interested in 
defining the neuropsychological characteristics of pre- 
clinical AD, subjects diagnosed as demented a t  baseline 
were excluded from these analyses. In addition, subjects 
with any of the following diagnoses a t  baseline were ex- 
cluded: “q~es t ionable”~ or borderline dementia, stroke, 
Parkinson’s disease, major depression, or a cognitive im- 
pairment of known etiology (eg, head trauma). 
Procedures. Subjects were evaluated annually, and re- 
ceived the same standardized assessment a t  each study 
visit. A physician conducted a standardized physical and 
neurologic examination and recorded each subject’s med- 
ical history. All available ancillary information, including 
medical records and imaging studies, was used in the 
evaluation. In addition, a brief (approximately 1 hour) 
neuropsychological test battery was administered. The 
neuropsychological battery was designed to assess a 
broad range of cognitive functions, and consisted primar- 
ily of subtests and short forms of widely used neuropsy- 
chological measures. Evaluations were conducted in ei- 
ther English or Spanish, based on the subject’s primary 
language and opinion of which language would yield bet- 
ter performance. To assure comparability of evaluations 
in English and Spanish, all interview questions, test in- 
structions, and stimuli were translated into Spanish and 
then translated back to ensure accuracy. Specific cogni- 
tive functions assessed and neuropsychological tests ad- 
ministered include the following: 
Word list learning and memorv. The SRTs was admin- 
istered. Subjects were given six trials to learn a list of 12 
unrelated words. After each recall attempt, a selective 
reminding procedure was used wherein subjects were re- 
minded only of those words that had not been success- 
fully recalled. To assess long-term retention of the word 
list, 15-minute delayed free recall was assessed, followed 
by a multiple-choice recognition task.  The predictive 
value of summed total recall across the six acquisition 
trials, total delayed recall, and total correct recognition 
was assessed. 
Nonverbal memory. A multiple-choice version of the 
Benton Visual Retention Test (BVRT)g was used to as- 
sess nonverbal memory. Subjects viewed a geometric de- 
sign for 10 seconds. It was then removed from view, and 
the subject was asked to recognize the design in a four- 
choice multiple-choice array. Stimuli corresponded to 
Form D of the original BVRT. 
Orientation. The 10 orientation items from the Mini- 
Mental State Examinationlo were used to assess orienta- 
tion to time and place. 
Verbal reasonin?. The Similarities subtest  of the  
WAIS-R,5 which requires subjects to identify relevant 
similarities or superordinate categories for paired items, 
was administered. The age-corrected scaled score was 
used in analyses. 
Nonverbal reasoning. The Identities and Oddities sub- 
test of the Mattis Dementia Rating Scale’l was used to 
assess nonverbal reasoning. In this test, subjects identify 
which two of three visually presented stimuli are the 
same. After all eight tr iads are  completed, the same 
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items are administered again, and the subject is required 
to identify the one item that is different. 
Naming. A 15-item version of the Boston Naming 
Test,I2 a test of visual confrontation naming, was used to 
assess word-finding ability. 
Verbal fluency. Letter and category fluency were as- 
sessed. For each trial, subjects were given 1 minute to 
generate as many words as possible. English-speaking 
subjects generated words beginning with the letters C, F, 
and L, while Spanish-speaking subjects generated words 
beginning with the letters P, S, and V. Different letters 
were used for Spanish- and English-speaking subjects to 
control for word-frequency differences across the two lan- 
guages: the letters C, F, L in English and P, S, V in 
Spanish are comparable in terms of number of words be- 
ginning with these letters. All subjects generated exem- 
plars in the categories animals, foods, and clothing. Aver- 
age fluency across the three trials for each type of task 
were used for analysis. 
Auditorv comprehension. The first six items of the 
Complex Ideational Material subtest of the Boston Diag- 
nostic Aphasia E~aminat ion’~  were used to assess com- 
prehension of spoken language. 
Repetition. Subjects were asked to repeat the high-fre- 
quency phrases from the Boston Diagnostic Aphasia Ex- 
amination Repetition of Phrases subtest.13 
Visuoconstructional skills. Subjects copied five de- 
signs from the Rosen Drawing Test14 ranging in difficulty 
from simple geometric shapes to overlapping, parallel, 
and three-dimensional figures. 
Visuoperceptual skills. Subjects matched a target de- 
sign to the same design presented simultaneously in a 
four-choice multiple-choice array containing the target 
along with three distractors. Target stimuli corresponded 
to Form C of the original BVRT.g 
Medical, historical, and neuropsychological data were 
reviewed at a diagnostic conference of physicians and 
neuropsychologists and a consensus diagnosis of the 
presence or absence of dementia was made. The diagno- 
sis of dementia was based on the criteria of the DSM-111- 
R15 and required evidence of cognitive deficit on the neu- 
ropsychological battery as well as evidence of impair- 
ment in social or occupational function. When dementia 
was diagnosed, all available data were examined to de- 
termine the etiology. NINCDS-ADRDA criteria16 were 
used for the diagnosis of probable and possible AD. 
Data analysis. We used Cox proportional hazards 
models17 to  assess the relative risk (RR) of incident de- 
mentia associated with baseline scores on the Boston 
Naming Test, WAIS-R Similarities, and Immediate Re- 
call on the SRT. Duration of follow-up was used as the 
timing variable for Cox analyses. For incident dementia 
cases with more than one follow-up visit, we used dura- 
tion from baseline to the first follow-up visit at which de- 
mentia was diagnosed; for subjects who remained nonde- 
mented, we used duration from baseline to the last avail- 
able follow-up visit. Age, education, sex, and language of 
test administration (English versus Spanish) were in- 
cluded in the model as covariates. All variates and co- 
variates were entered into the model simultaneously; 
thus, the RR associated with each variable was indepen- 
dent of all other variates and covariates. 
Two supplementary Cox analyses also were per- 
formed. In one analysis, additional neuropsychological 
measures were entered in a stepwise fashion to deter- 
mine whether any of the other variables in our test bat- 
tery provided an  independent contribution to the predic- 
tor model above and beyond our three a priori selected 
measures (ie, Boston Naming Test, WAIS-R Similarities, 
and SRT Immediate Recall). Second, since previous re- 
ports have suggested that delayed recall on the SRT is a 
good predictor of subsequent dementia in initially nonde- 
mented elderly people,* we performed a Cox regression 
using Delayed Recall rather than Immediate Recall on 
the SRT as the measure of memory function. 
Results. At least  one follow-up evaluation was 
available for 449 subjects who had no baseline di- 
agnosis of dementia or other disorder likely to af- 
fect cognition. Six of these cases were excluded 
from analyses because of missing data.  The re- 
maining 443 subjects were included in the  Cox 
analyses. The mean age of the subject sample was 
73.32 (k7.05) years, and the average level of educa- 
tion was 10.60 (k4.60) years. The group was 73% 
women and 38% Spanish-speaking. The overall av- 
erage duration of follow-up was 2.05 (k0.81) years. 
Forty-one of the 443 initially nondemented sub- 
jects had diagnosed AD a t  follow-up. Demographic 
characteristics of subjects who did and did not be- 
come demented are presented in table 1. Patients 
with incident dementia were older and less edu- 
cated than subjects who remained nondemented. 
There were no significant differences between the 
two groups in distribution of sex or language. 
Thirty-one of the 4 1  patients with incident de- 
mentia had a diagnosis of probable AD; the remain- 
ing 10 were diagnosed as having possible AD with 
other concomitant illnesses that were thought pos- 
sibly to have contributed to  the change in mental 
status but did not completely account for it. Con- 
comitant illnesses included cerebrovascular acci- 
dents (CVAs), hypothyroidism, and systemic ill- 
nesses. There were no incident cases of vascular 
dementia. This is likely due, in part, to the fact 
that we excluded from these analyses subjects with 
a history of stroke at baseline. The clinical course 
in those subjects diagnosed as having possible AD 
and concomitant CVA was consistent with possible 
AD, including insidious onset of symptoms and 
gradual decline. In  some cases, the strokes were 
clinically “silent,” but evident on CT. 
When baseline test scores were treated as con- 
tinuous variables, a lower score on the  Boston 
Naming Test, WAIS-R Similarities, ’or SRT Imme- 
diate Recall was significantly and independently 
associated with increased risk for subsequent AD 
diagnosis, even after controlling for age, educa- 
tional attainment, sex, and language of test admin- 
istration (see table 2). Age and sex also provided a 
significant contribution to the Cox model. When 
the Cox regression was repeated with only the 31  
subjects diagnosed as having probable AD included 
as incident cases, the Boston Naming Test (p = 0.7; 
95% CI = 0.6 to 0.8), WAIS-R Similarities Cp = 0.7; 
95% CI = 0.6 to 0.91, and SRT Immediate Recall Cp 
= 0.9; 95% CI = 0.8 to 0.9) remained strong and in- 
dependent predictors of subsequent dementia. 
In order to aid in the interpretation of RR val- 
ues, we also dichotomized baseline test  perfor- 
Table 1. Characteristics of subjects who did 
and did not become demented 
I 
Incident No incident 
dementia dementia 
(N = 41) (N = 402) 
Mean (SD) age 
Mean (SD) education 
Sex (% female) 
Language (% Spanish) 






















* Percentage of each group completing follow-up evaluations 1 to 4 
years after baseline. For incident dementia cases, duration from 
baseline to the first follow-up visit a t  which dementia was diag- 
nosed is reported. For subjects who remained nondemented, dura- 
tion from baseline to the last available follow-up visit is reported. 
Table 2. Risk ratios for incident Alzheimer’s 
disease associated with baseline test scores 
Adjusted 95% Confidence 
Variable* risk ratio interval 
Age 1.1 1.0-1.1 
Education 0.9 0.9-1.0 
Sex (female) 2.5 1.1-5.9 
Language (Spanish) 0.6 0.3-1.3 
Boston Naming Test 0.8 0.7-0.9 
WAIS-R Similarities 0.8 0.6-0.9 
SRT Immediate Recall 0.9 0.9-1.0 
* Variables were continuous, with the exception of sex and 
language. Adjusted risk ratios for continuous variables 
represent relative risk of incident dementia per  un i t  
change (per point difference) independent of the  other 
variables in the model. 
WAIS-R Wechsler Adult Intelligence ScalCRevised. 
SRT Buschke Selective Reminding Test. 
I 
mance into impaired and unimpaired ranges, and 
examined the RR associated with a score in the im- 
paired range. Impairment was defined as a score 
more than two SDs below the mean scores of a 
group of 322 cognitively normal older adults from 
the same community-based cohort. Scoring in the 
impaired range on the Boston Naming Test, WAIS- 
R Similarities, or SRT Immediate Recall was sig- 
nificantly and independently associated with in- 
creased risk for subsequent AD diagnosis, again 
after controlling for age, education, sex, and lan- 
guage of test administration (see table 3). Further, 
the risk of subsequent AD associated with baseline 
scores in the impaired range on any two of these 
measures increased approximately five-fold and, if 
baseline scores on all three measures were in the 
impaired range, twelve-fold. 
Supplementary analyses. Results of t h e  Cox 
analyses with stepwise inclusion of additional neu- 
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Table 3. Risk ratios for incident Alzheimer’s 
disease associated with baseline test scores in the 
impaired range (2 SD below the mean) 
Variable 
Adjusted 95% Confidence 
risk ratio interval 
Age 1.1 1.1-1.2 
Education 0.9 0.8-1.0 
Sex (female) 1.7 0.7-3.9 
Language (Spanish) 0.7 0.3-1.4 
Boston Naming Test 2.4 1.2-4.7 
WAIS-R Similarities 2.5 1.2-5.1 
SRT Immediate Recall 2.1 1.0-4.2 
I WAIS-R Wechsler Adult Intelligence Scale-Revised. SRT Buschke Selective Reminding Test. 
ropsychological measures revealed that the vari- 
able with the greatest additional contribution to 
the predictor model (ie, after inclusion of the 
Boston Naming Test, WAIS-R Similarities, SRT 
Immediate Recall, and the demographic covariates) 
was our measure of nonverbal memory, BVRT 
Recognition (RR = 1.29; 95% CI = 1.09 to 1.52). 
After BVRT Recognition was included in the model, 
no other variable provided a significant indepen- 
dent contribution. 
There was a high correlation between SRT Im- 
mediate and Delayed Recall (r = 0.74; p < O.OOOl), 
so when both variables were included in the model, 
neither made a significant independent contribu- 
tion. Therefore, a separate Cox analysis was per- 
formed that included SRT Delayed Recall, rather 
than Immediate Recall, in the model with Boston 
Naming Test, WAIS-R Similarities, and the demo- 
graphic covariates (ie, age, education, sex, and lan- 
guage). When treated as a continuous variable, 
poor baseline performance on SRT Delayed Recall 
was associated with a significantly increased risk 
of subsequent AD diagnosis (RR = 1.4; 95% CI = 1.2 
to 1.7). When dichotomized, however, scoring in the 
impaired range at baseline on SRT Delayed Recall 
was not associated with increased risk of later AD 
(RR = 2.4; 95% CI = 0.7 to 8.6). 
Discussion. The results of this study confirm our 
preliminary findings and corroborate the recently 
published report of Masur et a14 indicating that the 
preclinical stages of AD are characterized by more 
than just  memory impairment. We found tha t  
changes in abstract reasoning and confrontation 
naming ability occur well before clinical signs of de- 
mentia are evident. Evaluation of these cognitive 
abilities in the context of a comprehensive demen- 
tia evaluation may assist in detecting AD in its ear- 
liest stages. 
The neuropsychological characteristics of pre- 
clinical AD described here are consistent with pre- 
vious reports of psychometric test performance in 
subjects with very mild AD.18-20 Welsh et  all8 re- 
ported that delayed recall on a list-learning task 
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was the best psychometric measure for differentiat- 
ing early AD from normal aging, and the only non- 
memory measure from the Consortium to Establish 
a Registry for Alzheimer’s Disease (CERAD) neu- 
ropsychological battery to assist in this discrimina- 
tion was an  abbreviated version of the Boston 
Naming Test. Storandt and Hill19 and Morris et aIz0 
also found poor confrontation naming in addition to 
impaired memory and psychomotor speed in very 
mildly demented AD patients. Our results suggest 
that the impairments in memory, naming, and ver- 
bal reasoning, often prominent in the early stages 
of dementia, can be detected even before functional 
impairment is evident and dementia is diagnosed. 
Our results lend further support to  the notion of 
a preclinical phase of AD. The neuropsychological 
measures detected subtle deficits of memory, ab- 
straction, and word-finding abilities in nonde- 
mented subjects who only later met criteria for AD. 
Although we cannot be certain that all of the 41 in- 
cident dementia cases were not already clinically 
demented at baseline, that  the subjects were de- 
mented and our procedures simply failed to detect 
it is unlikely. At baseline, no subject had difficulty 
in social or occupational functioning due to cogni- 
tive impairment. Each subject was examined by a 
behavioral neurologist who assessed mental status 
without prior knowledge of the subject’s perfor- 
mance on neuropsychological testing. Neurologists 
diagnosed all subjects as nondemented at  baseline, 
with four exceptions (two incident AD cases and 
two subjects who remained nondemented). At the 
diagnostic consensus conference, where a team of 
neurologists and neuropsychologists reviewed sub- 
jects’ medical and social histories and neuropsycho- 
logical test scores, diagnoses for these four subjects 
were changed to nondemented. For completeness, 
the Cox models were re-run without these four sub- 
jects, and results essentially were unchanged; the 
three neuropsychological measures remained sig- 
nificant and independent predictors of subsequent 
dementia. Although the diagnosis of dementia was 
based in part on the neuropsychological tests, we 
never based diagnoses solely on these measures but 
considered subjects’ day-to-day functioning, medi- 
cal histories, examination findings, and test results 
in the diagnostic process. We never diagnosed de- 
mentia in the absence of a history of functional de- 
cline, regardless of neuropsychological test scores. 
In addition to the independent neurologic and 
neuropsychological assessment of each subject, a po- 
tentially useful adjunct to our assessment proce- 
dures would be an informant-based rating of sub- 
ject’s functional status. Koss et alZ1 and Morris et 
alZo demonstrated that collateral sources, such as 
spouses or caregivers, generally appraise and report 
accurately cognitive and functional deficits in AD 
patients, even those with very mild or “questionable” 
dementia. Implementing informant-based assess- 
ments in our community-based cohort has been diffi- 
cult, however, because many of the subjects live 
alone, and a reliable informant may not be available. 
The neuropsychological characteristics of pre- 
clinical AD differ in magnitude and scope from 
those associated with age-associated memory im- 
pairment (AAMI). The diagnostic criteria for AAMI 
include complaints of memory loss and objective 
memory test performance that  is at least 1 S D  
below the normative mean for young adults, in the 
absence of dementia and presence of adequate in- 
tellectual function.22 Koivisto et  a123 recently re- 
ported a high prevalence rate of AAMI (38.4%) in a 
randomly selected population of older adults from 
eastern Finland, and concluded that AAMI charac- 
terizes a phenomenon of normal aging rather than 
a distinct clinical entity. In contrast, our initially 
nondemented subjects who subsequently developed 
AD scored lower on neuropsychological tests not 
only relative to  young adults, but also when com- 
pared with peers of comparable age. In addition, 
poor naming and verbal abstract reasoning inde- 
pendently were associated with preclinical AD. 
Performance on nonmemory tests of cognitive func- 
tion are not addressed in the diagnostic criteria for 
AAMI. 
The current study has several advantages com- 
pared with some of the previous prospective neu- 
ropsychological investigations of preclinical demen- 
tia. Fuld et al,’ Masur et a1,2 and Tuokko et a13 re- 
stricted the assessment of cognition in their nonde- 
mented elderly subjects to measures of memory. In 
the current study, we, like Masur et al,4 used a 
comprehensive neuropsychological test battery that 
assessed a range of cognitive domains. By system- 
atically assessing diverse cognitive abilities, we 
were able to  delineate various intellectual skills 
that are affected early in the course of AD. A poten- 
tial limitation of our study, however, is that  the 
tasks within our neuropsychological battery may 
not be of comparable difficulty. Therefore, addi- 
tional abilities, for example constructional skills, 
may also be affected in preclinical AD, but our in- 
struments may not be sensitive enough to detect 
subtle changes. Nevertheless, our finding tha t  
naming and abstract reasoning are affected in pre- 
clinical AD, in addition to memory, corroborates 
and extends the results of Masur et a14 that cogni- 
tive abilities other than memory are impaired in 
nondemented older adults who subsequently de- 
velop clinically significant dementia. 
A second advantage of the current study is our 
use of Cox modeling to assess the RR of incident 
dementia associated with baseline test scores. Pre- 
vious investigations generally have relied upon 
univariate estimates of test sensitivity, specificity, 
and predictive value. The benefits of Cox analysis 
include the inclusion of time in the predictor model; 
thus, it is not necessary to limit follow-up to a spe- 
cific interval. In addition, by including duration of 
longitudinal follow-up in the model, Cox analysis 
controls for differences across subjects in terms of 
the opportunity to reach the endpoint (ie, become 
demented). Cox analysis also provides the ability to  
assess the effects of one variate while simultane- 
ously controlling for the effects of other variates 
and covariates. Previous studies often have failed 
to  address potential differences between incident 
cases and subjects who remain nondemented in 
terms of demographic variables that can affect neu- 
ropsychological test performance, such as age and 
level of education. Failure to  control for these im- 
portant confounders can lead to erroneous interpre- 
tation of the neuropsychological data. 
As is common to many clinical studies of AD, our 
findings are limited by inability to validate the di- 
agnosis of probable or possible AD. Although 16 of 
the subjects included in the analyses presented 
here (four incident dementia cases and 12 subjects 
who remained nondemented) have died, none had a 
postmortem examination. Thus, we are unable to 
confirm the diagnosis of probable or possible AD in 
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The P1 component of the middle 
latency auditory evoked potential 
predicts a practice effect during 
clinical trials in Alzheimer’s disease 
Joseph B. Green, MD; William W. Elder, BS; and David M. Freed, PhD 
Article abstract-Thirty-five patients with probable Alzheimer’s disease who were enrolled in an  experimental drug 
trial of linopirdine underwent repeated testing that included recording the middle latency auditory evoked potential 
(MLAEP), the Mini-Mental State Examination (MMSE), and the Alzheimer’s Disease Assessment Scale Cognitive Sub- 
scale (ADASCOG). Patients lacking the P1 component of the MLAEP exhibited a significantly greater decline in cogni- 
tive function as measured by the ADASCOG over 56 weeks. This decline appeared to be due to a less robust practice ef- 
fect, which was maximal in all patients at 16 weeks. At the end of 56 weeks the entire group of patients was near base- 
line with respect to the ADASCOG. This lack of the annualized decline expected from other longitudinal studies may 
be explained by practice and placebo effects. The MMSE did not exhibit a practice effect and showed the expected de- 
cline in scores. 
NEUROLOGY 1995;45:962-966 
Buchwald et all first reported the P1 component of 
the middle latency auditory evoked potential 
(MLAEP) to be absent in Alzheimer’s disease (AD), 
and Green et a12 later confirmed this finding. We 
have found P1 to be absent in 47.5% of 101 patients 
with probable AD (unpublished data). The goal of 
the current study was to  determine if AD patients 
lacking the P1 response differ with respect to  clini- 
cal course and cognitive decline. In the course of 
this study, which lasted 56 weeks, we obtained im- 
portant data concerning practice and placebo ef- 
fects that may provide guidance in planning future 
clinical drug trials in AD. 
Methods. The subjects of this investigation were 35 pa- 
tients with probable AD who were enrolled in a clinical 
trial of a putative cognition-enhancing drug, linopirdine. 
Patients were receiving either drug or placebo and were 
followed for a total of 56 weeks. Patients were thoroughly 
evaluated with repeated neurologic examinations and 
imaging studies. The protocol of the study required the fol- 
lowing to be completed at screening and during regular in- 
tervals: the Hachinski Ischemia Scale, the Mini-Mental 
State Examination (MMSE), the Hamilton Depression 
Scale, the Alzheimer’s Disease Assessment Scale (ADAS), 
Word Recall task,  Word Recognition task,  Syndrom 
Kurztest, Instrumental Activities of Daily Living Scale 
(Lawton-Brody), Dementia Behavior Disturbance Scale, 
and Clinical Global Impressions. In addition, most pa- 
tients also had neuropsychological testing prior to screen- 
ing, commonly the CERAD battery. The diagnosis of prob- 
able AD was made in accordance with NINCDS-ADRDA 
 guideline^.^ All patients and guardians gave informed con- 
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